Immuron (IMRN) Interest & Investment Income (2017 - 2024)
Immuron's quarterly Interest & Investment Income came in at $35.3 billion in Q4 2024, up 23001335.32% year-on-year from N/an in Q1 2024, and up 23001335.32% quarter-over-quarter from $153508.0 in Q4 2023.
Immuron has reported Interest & Investment Income for 8 years, with the latest figure at $35.3 billion in Q4 2024.
- For the quarter ending Q4 2024, Interest & Investment Income rose 23001335.32% year-over-year to $35.3 billion; the trailing twelve-month figure through Dec 2024 stood at $35.3 billion (up 30910386.56% YoY), and the FY2025 full-year result was $88058.7, down 59.03% from the prior year.
- Interest & Investment Income for Q4 2024 stood at $35.3 billion, up from $153508.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $35.3 billion in Q4 2024, with the low at -$77745.7 in Q2 2023.
- Average Interest & Investment Income over 5 years is $4.4 billion, with a median of $69.33 recorded in 2020.
- Year-over-year, Interest & Investment Income plunged 398.25% in 2023 and jumped 23001335.32% in 2024.
- Tracing IMRN's Interest & Investment Income over 5 years: stood at $63.29 in 2020, then gained by 19.09% to $75.37 in 2021, then soared by 71641.42% to $54072.0 in 2022, then jumped by 183.9% to $153508.0 in 2023, then jumped by 23001335.32% to $35.3 billion in 2024.
- The last three Interest & Investment Income figures came in at $35.3 billion (Q4 2024), $153508.0 (Q4 2023), and -$77745.7 (Q2 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 305,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Immuron | 1.27 Bn | 1.27 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 35.31 Bn |
| Dec 31, 2023 | 153,508.00 |
| Jun 30, 2023 | -77,745.69 |
| Dec 31, 2022 | 54,072.00 |
| Jun 30, 2022 | -15,603.91 |
| Dec 31, 2021 | 75.37 |
| Jun 30, 2021 | -7,087.59 |
| Dec 31, 2020 | 63.29 |
| Dec 31, 2019 | 2.59 |
| Dec 31, 2018 | 39.00 |
| Dec 31, 2017 | 33.51 |